Clinical Trials in Pain Research Marten Harbers, PhD Director Project Delivery – Early Development Services Learn more about our pain studies here. SEPTEMBER 25, 2018 Pain is one of the most common symptoms reported by patients in many therapeutic areas, making proper...
How Will Brexit Impact Pharma? Jurij Petrin, MD Senior Vice President Global Regulatory Affairs MAY 10, 2018 Brexit is currently projected to occur on 30 March 2019. Unless the UK and EU politicians find a solution to cancel or at least postpone it, after that date...
CAR T-Cell Therapies – The Holy Grail of Therapeutic Innovation in Hemato-Oncology and its Challenges from a CRO Perspective
CAR T-Cell Therapies – The Holy Grail of Therapeutic Innovation in Hemato-Oncology and its Challenges from a CRO Perspective Giuseppe Lentini, MD Senior Medical Director, Hematology/Oncology – Medical Affairs DECEMBER 5, 2018 Since the approval of the first IND...
Bridging Recruitment Gaps with Academic Collaboration Dr. Alexandre Malouvier, Scientific Affairs Director, Real World Solutions DECEMBER 5, 2018 As the pharmaceutical industry is rapidly changing, many roles and relationships within it are going through a major...read more
Winning Team: Working With a Service Dog Billy DeWalt and his wife, Jen Note from Billy: If anyone reading this wants to jump in on the Tobacco Road Marathon, feel free! The course is great for beginners to seasoned runners and is also walker and ruck friendly. If...read more
Making Clinical Trial Recruitment More Efficient Larissa Silva, MD Buenos Aires, Argentina Rebecca Sayers, PhD Raleigh, North Carolina, United States Jens Dietrich, PhD Berlin, Germany Russell Brown, PharmD, PhD South Yarra, Victoria, Australia NOVEMBER 26,...read more
Lung Cancer Awareness Month Stephen Huff Founder of The Huff Project NOVEMBER 6, 2018 Stephen Huff was diagnosed with stage IV inoperable lung cancer at the age of 29. Prior to his diagnosis, Stephen lived an incredibly healthy and clean lifestyle. As a former...read more
Literature Surveillance: From Abundance to Relevance Andrew Purchase Associate Director of Patient Safety Operations, PV and Patient Safety NOVEMBER 1, 2018 Literature is regarded as a significant source of information in the monitoring of a medicinal product, and...read more
Advocacy Groups in Patient-Focused Drug Development Juliane K. Mills Director, Real World Solutions - Scientific Affairs Kendall Davis Manager, Patient Advocacy & Engagement Juliane Mills hosted an Xtalks webinar on Thursday, November 8, 2018 to discuss how the...read more
When Volunteering is Part of Who You Are Mark Sorrentino VP, The Center for Pediatric Clinical Development We're so proud that Mark was awarded with The President's Volunteer Service Award in recognition of all his efforts in 2018. OCTOBER 24, 2018 At PRA, a...read more
Children in Clinical Research Harris Dalrymple Director of Scientific Affairs PRA is a proud presenting sponsor of ACS CAN's ninth annual Research Breakfast, which focuses on the barriers to cancer clinical trial enrollments and efforts to overcome them. OCTOBER 10,...read more
Biologic Agents for the Treatment of Rheumatoid Arthritis Maria Victoria Hernandez MD, PhD Medical Director, Rheumatology - Medical Affairs OCTOBER 9, 2018 Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease affecting around 1.5 million people...read more
Enrollment in Cancer Clinical Trials Christine Weason ACS CAN North Carolina government relations director PRA is a proud presenting sponsor of ACS CAN's ninth annual Research Breakfast, which focuses on the barriers to cancer clinical trial enrollments and efforts...read more
Neurodegenerative Research: A Future Mindset
PRA’s William Holt, DO, discusses the critical need for research into Neurodegenerative disorders, with particular emphasis on the future of clinical development and Alzheimer’s Disease research.